Related Articles
Molecular and cellular mechanisms of castration resistant prostate cancer (Review)
Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells
Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells
Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer